Article
FDX1 serves as a prognostic biomarker and promotes glioma progression by regulating the immune response
10 Jun 2023
Abstract excerpt
The present study investigates the prognostic value of the FDX1 gene and its association with immune infiltration in gliomas. Gene expression profiles and corresponding clinical parameters of glioma patients were obtained from the Cancer Genome Atlas and Chinese Glioma Genome Atlas databases. In vitro experiments were also performed to validate its impact on malignant phenotypes of glioma cells. Kaplan-Meier...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
